BeiGene's Tevimbra wins FDA approval for first-line metastatic ESCC treatment, showing significant survival benefits in PD-L1 ...

TEVIMBRA is a uniquely designed humanized immunoglobulin G4 (IgG4) anti-programmed cell death protein 1 (PD-1) monoclonal antibody with high affinity and binding specificity against PD-1. It is ...

The FDA approved Tevimbra with chemotherapy for adults with unresectable or metastatic esophageal squamous cell carcinoma ...

Tislelizumab plus chemotherapy received FDA approval as a frontline therapy for individuals with unresectable or metastatic ...

Tislelizumab plus chemotherapy is now FDA-approved for metastatic esophageal squamous cell carcinoma with a tumor PD-L1 ...

Breast cancer survivors treated with chemotherapy tend to suffer a longer-lasting decline in their physical health, c ...

A brain cancer patient has been left "confused" and "shattered" after learning he took chemotherapy drugs needlessly for more ...

Chinese University team reports encouraging results and is recruiting more patients to include in CAR-T clinical trial ...

At MedStar Georgetown University Hospital, robots are assisting pharmacists with mixing and delivering some of the most ...

A study that took place in the Capital Region turned up groundbreaking findings. Experts said it’s changed the standard of ...

The first patient with small cell lung cancer has been dosed in a trial of peluntamig (PT217) combined with chemotherapy.